Extensive-Stage Small Cell Lung Cancer Treatment | TECENTRIQ® (atezolizumab)

🧬 Big news in lung cancer treatment: The U.S. Food and Drug Administration has approved a new combination therapy for adults with extensive-stage small cell lung cancer (ES-SCLC). Zepzelca (lurbinectedin) Tecentriq (atezolizumab) or Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs) can now be used as maintenance therapy for people with ES-SCLC whose disease has not progressed after initial first-line treatment. Based on results from the IMforte study, people with ES-SCLC stayed on treatme

Expert Insights on First-line Treatment Strategies in SCLC